Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss in Cronkhite-Canada syndrome is reversible by treating the gut issues and doesn't need steroid treatment for the hair itself.

Recurrent NICF is a rare skin condition with unclear causes, involving follicle inflammation and crystal deposits.

ICL is a condition with low CD4+ T cells like AIDS but not caused by HIV, and normal CD4+ T cell counts may vary between men and women.

A mother and son both had ulcerative colitis and alopecia, suggesting a genetic link in autoimmune disorders and successful treatment with cyclosporine.

Early recognition and management of gastrointestinal tuberculosis in lupus patients are crucial to prevent complications.

A woman with both Cronkhite-Canada syndrome and myelodysplastic syndrome improved significantly with corticosteroid treatment.

A man with Cronkhite-Canada syndrome had all 20 nails detach but improved with treatment.

Some patients temporarily lost hair after a certain bowel surgery, but it grew back without needing special treatment.

Long-term data and a team approach are needed to manage chronic side effects from cancer treatments.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Ulcerative colitis involves immune activation, chronic inflammation, and metabolic issues, some of which persist even during remission.

Consider infectious diseases like visceral leishmaniasis before diagnosing autoimmune hepatitis.

A 13-year-old girl with various symptoms was successfully treated with an antibiotic called co-trimoxazole.

Hair loss in Cronkhite-Canada syndrome may be due to an autoimmune response.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

Regular endoscopic checks are crucial for Cronkhite-Canada syndrome patients to catch potential cancers early.

A 78-year-old man with Cronkhite-Canada syndrome improved significantly after treatment and remains symptom-free.

The man was diagnosed with Cronkhite-Canada syndrome, a rare disorder with GI polyps, skin issues, hair loss, and nail problems.

Systemic lupus erythematosus caused severe abdominal issues in a Sudanese woman.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

Consider DRIF and perform skin biopsies for persistent papular rashes.

Baricitinib may reactivate trichilemmal cysts in people with a history of these cysts.

Some treatments for inflammatory bowel disease can cause skin problems like rashes and melanoma.

A CCS patient with severe complications was successfully treated using combined therapies.

Inflammation may cause nail issues in Cronkhite–Canada Syndrome.

A patient with Cronkhite-Canada Syndrome developed colon cancer that spread to the liver, showing the need for regular cancer checks in such patients.

A patient with Cronkhite-Canada syndrome improved with nutritional support and steroids, but early diagnosis is key due to high mortality.

Isotretinoin reduced inflammation in tufted hair folliculitis, but hair tufting remained.

A novel CLDN1 mutation in a 2-month-old with NISCH showed improvement with symptom management.